Cargando…
Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations
PURPOSE: Familial adenomatous polyposis (FAP) has an almost 100% colorectal cancer risk warranting early detection in gene carriers. This study presents congenital hypertrophy of the retinal pigment epithelium (CHRPE) as a highly specific phenotypical marker for FAP that can be used in screening at-...
Autores principales: | Bonnet, Louis Antoine, Conway, R Max, Lim, Li-Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934868/ https://www.ncbi.nlm.nih.gov/pubmed/35321042 http://dx.doi.org/10.2147/OPTH.S354761 |
Ejemplares similares
-
Congenital hypertrophy of retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (FAP); a polyposis registry experience
por: Nusliha, Anwer, et al.
Publicado: (2014) -
Congenital Hypertrophy of Retinal Pigment Epithelium for Diagnosis of Familial Adenomatous Polyposis - the First FAP registry in Iran
por: Mirinezhad, Seyed Kazem, et al.
Publicado: (2018) -
Suspect asymptomatic lesions: Congenital hypertrophy of the Retinal Pigment Epithelium (CHRPE)
por: Braga, Carolina Serpa, et al.
Publicado: (2021) -
The link between colon cancer and congenital hypertrophy of the retinal pigment epithelium (CHRPE)
por: Deibert, Brent, et al.
Publicado: (2019) -
Atypical hypertrophy of retinal pigment epithelium manifesting as the first sign of familial adenomatous polyposis
por: Ponces Ramalhão, João, et al.
Publicado: (2023)